NAVB

Navidea Biopharmaceuticals Inc.
NAVB

Overview Fund Activity
Delisted

NAVB was delisted on the 5th of October, 2023.

Back to rankings

31 hedge funds and large institutions have $3.13M invested in Navidea Biopharmaceuticals Inc. in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 8 closing their positions.

Holders
31
Holders Change
-4
Holders Change %
-11.43%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
11
Reduced
5
Closed
8
Calls
$385K
Puts
$566K
Net Calls
-$181K
Net Calls Change
-$160K

Top Buyers

1
BlackRock
1
BlackRock
New York
$315K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$77K
3
Two Sigma Advisers
3
Two Sigma Advisers
New York
$281K
4
State Street
4
State Street
Massachusetts
$44K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$177K

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$0
2
BCM
2
Bridgeway Capital Management
Texas
$187K
3
Two Sigma Investments
3
Two Sigma Investments
New York
$189K
4
Squarepoint
4
Squarepoint
New York
$0
5
Group One Trading
5
Group One Trading
Illinois
$1K
Name Holding Trade Value Shares
Change 		Shares
Change %
Renaissance Technologies
26
Renaissance Technologies
New York
– -$266K -131,618 Closed
Squarepoint
27
Squarepoint
New York
– -$58K -28,836 Closed
California Public Employees Retirement System
28
California Public Employees Retirement System
California
– -$37K -18,385 Closed
Wolverine Trading
29
Wolverine Trading
Illinois
– -$22K -11,219 Closed
SFS
30
Sowell Financial Services
Arkansas
– -$18K -11,190 Closed
TRCT
31
Tower Research Capital (TRC)
New York
– -$2K -783 Closed
1
2